Podcast thumbnail for The 2 Minute Medicine® Podcast

The 2 Minute Medicine® Podcast

Claim This Podcast

by 2 Minute Medicine®

5.0(4 reviews)
76 episodes
Updated Weekly
Accepts GuestsHas SponsorsLocation 🇺🇸
29

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality33
Social0
YouTube0
Engagement60

Podcast Overview

Welcome to the 2 Minute Medicine® (est. 2013) Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in health care news and research evidence. Please visit our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series, and The Scan, our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed.

Language

🇺🇲

Publishing Since

11/3/2022

Unlock The Full Podcast Authority Score Report

See how your podcast performs across key metrics

29

Podcast Authority

Beta
PoorBased on show quality, social media presence, reviews, charts, and more
Pod Engine
Quality33
Social0
YouTube0
Engagement60
6
Excellent Areas
0
Good Performance
13
Growth Opportunities
excellent
Episode Length
8 minutes
Performing excellently!
needs improvement
Publishing Consistency
Every 16 days

Recommendations available

Unlock the full report to see detailed tips

+16 More Metrics

Unlock comprehensive insights including:

  • • YouTube presence analysis
  • • Social media reach metrics
  • • RSS compliance scoring
  • • Podcast 2.0 features
  • • Technical standards
What's Included in Your Full Report

Detailed Analytics

  • Complete breakdown of all 19 authority metrics
  • Personalized recommendations for each metric
  • Industry benchmarks and comparisons
  • Technical RSS feed analysis and compliance scoring

Growth Strategies

  • Step-by-step action plans for improvement
  • Quick wins to boost your score immediately
  • Pro tips from successful podcasters
Get your free podcast insights report

See how your show performs across every key metric

Instant delivery
No spam
Attract Better Guests

High authority scores make your podcast more attractive to industry leaders and influencers who want to appear on credible shows.

Secure Sponsorships

Sponsors look for podcasts with proven authority and engagement. Your score demonstrates your podcast's value to potential partners.

Grow Your Audience

Understanding your strengths and weaknesses helps you make data-driven decisions to expand your listener base effectively.

1 verified contact email on file for The 2 Minute Medicine® Podcast

Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.

Recent Episodes

Episode thumbnail for The 2 Minute Medicine® Podcast – Shingles Vaccine Linked to Lower Dementia Risk, Whole-Body MRI Screening, Andes Hantavirus, GLP-1 Emotional Blunting, and “Cortisol Face”

July 1, 2026

The 2 Minute Medicine® Podcast – Shingles Vaccine Linked to Lower Dementia Risk, Whole-Body MRI Screening, Andes Hantavirus, GLP-1 Emotional Blunting, and “Cortisol Face”

<p>In this episode, we explore how artificial intelligence is continuing to move deeper into healthcare infrastructure and clinical practice. We begin with the Food and Drug Administration&#39;s review of an artificial intelligence tool designed to predict drug-induced liver injury during drug development. We then examine a new certification program launched by The Joint Commission focused on responsible artificial intelligence governance in healthcare organizations. Finally, we discuss how pediatric hospitals are beginning to deploy generative artificial intelligence tools to reduce administrative burden and support clinical workflows.</p>

Episode thumbnail for The 2 Minute Medicine® Podcast - Shingles Vaccine & Dementia Risk, Whole-Body MRI Scans, Andes Hantavirus, GLP-1 Emotional Blunting, and "Cortisol Face"

June 24, 2026

The 2 Minute Medicine® Podcast - Shingles Vaccine & Dementia Risk, Whole-Body MRI Scans, Andes Hantavirus, GLP-1 Emotional Blunting, and "Cortisol Face"

<p>In this episode, we explore how social media, celebrity influence, and emerging science continue to shape healthcare conversations around the world. The article of the week comes from from Annals of Internal Medicine entitled “Dementia Risk After Recombinant Herpes Zoster Vaccination in Older Adults With a Recent Skilled-Nursing Facility Stay: A Target Trial Emulation.” In the second half, we take a deep dive into the growing whole-body MRI screening trend promoted by celebrities and the concerns radiologists are raising about incidental findings and unnecessary follow-up testing. We then examine a rare Andes hantavirus outbreak aboard an expedition cruise ship that prompted contact tracing efforts across 32 countries. Next, we discuss reports of emotional blunting among some patients taking GLP-1 receptor agonists alongside new genetic data that may explain why certain individuals do not respond to these medications. Finally, we break down the viral “cortisol face” trend and why endocrinologists are cautioning against unnecessary cortisol testing.</p>

Episode thumbnail for The 2 Minute Medicine® Podcast- Talzenna in Prostate Cancer, Safer Anticoagulation Strategies, Retatrutide’s Metabolic Impact, and FDA Oversight of GLP-1 Therapies Summary:

May 7, 2026

The 2 Minute Medicine® Podcast- Talzenna in Prostate Cancer, Safer Anticoagulation Strategies, Retatrutide’s Metabolic Impact, and FDA Oversight of GLP-1 Therapies Summary:

<p>In this episode of the 2 Minute Medicine® Podcast, we explore major advances in precision medicine, beginning with the Phase 3 TALAPRO-3 trial demonstrating improved outcomes with talazoparib combined with enzalutamide in metastatic prostate cancer. We review new evidence from the COBRRA trial comparing apixaban and rivaroxaban, highlighting a significantly improved bleeding profile without loss of efficacy. The episode then examines Eli Lilly’s investigational triple-agonist retatrutide, which is showing unprecedented weight loss and glycemic control in patients with type 2 diabetes. Finally, we discuss a recent FDA warning issued to Novo Nordisk regarding delayed adverse event reporting and what this means for clinicians as GLP-1 therapies continue to expand rapidly in clinical practice.</p>

76 total episodes available

Deep-dive analytics for The 2 Minute Medicine® Podcast

Frequently asked questions

Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.

What is The 2 Minute Medicine® Podcast?

Welcome to the 2 Minute Medicine® (est. 2013) Podcast, summarizing the latest medical studies, curated and written by practicing physicians. On this podcast, twice a month, we cover the latest in health care news and research evidence. Please visit our website at 2minutemedicine.com to learn more and to access all of our content including medical study summaries, visual abstracts, excerpts from our Classics book series, and The Scan, our medical newsletter. To make sure that you don’t miss any of our content please subscribe and follow us on Twitter or Instagram @2minmed.

How often does this podcast release new episodes?

This podcast updates weekly.

Where can I listen to this podcast?

This podcast is available on 6 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.

Does this podcast accept guests?

No, this podcast does not typically feature guests.

Legal Disclaimer

Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.

All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.

We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.

While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.

By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.